Mark Hillman's CVS Position Overview
Mark Hillman (via Hillman Capital Management, Inc.) currently holds 71,685 shares of CVS Health Corporation (CVS) worth $5.69 M, representing 3.58% of the portfolio. First purchased in 2019-Q4, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Mark Hillman has maintained a strategic position in CVS, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 16,613 shares. Largest reduction occurred in Q1 2025, reducing 19,186 shares.
Analysis based on 13F filings available since 2013 Q2
Mark Hillman's CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by Mark Hillman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -10,674 | Reduce 12.96% | 71,685 | $79.36 |
| Q3 2025 | -10,638 | Reduce 11.44% | 82,359 | $75.39 |
| Q2 2025 | -7,453 | Reduce 7.42% | 92,997 | $68.98 |
| Q1 2025 | -19,186 | Reduce 16.04% | 100,450 | $67.75 |
| Q4 2024 | -1,891 | Reduce 1.56% | 119,636 | $44.89 |
| Q3 2024 | -2,802 | Reduce 2.25% | 121,527 | $62.88 |
| Q2 2024 | +10,291 | Add 9.02% | 124,329 | $59.06 |
| Q1 2024 | +376 | Add 0.33% | 114,038 | $79.76 |
| Q4 2023 | +1,354 | Add 1.21% | 113,662 | $78.96 |
| Q3 2023 | +16,613 | Add 17.36% | 112,308 | $69.82 |
| Q2 2023 | -652 | Reduce 0.68% | 95,695 | $69.13 |
| Q1 2023 | +712 | Add 0.74% | 96,347 | $74.31 |
| Q4 2022 | -707 | Reduce 0.73% | 95,635 | $93.19 |
| Q3 2022 | -968 | Reduce 0.99% | 96,342 | $95.37 |
| Q2 2022 | -173 | Reduce 0.18% | 97,310 | $92.66 |
| Q1 2022 | -11,615 | Reduce 10.65% | 97,483 | $101.22 |
| Q4 2021 | -3,743 | Reduce 3.32% | 109,098 | $103.16 |
| Q3 2021 | +3,912 | Add 3.59% | 112,841 | $84.86 |
| Q2 2021 | +710 | Add 0.66% | 108,929 | $83.44 |
| Q1 2021 | +13,954 | Add 14.80% | 108,219 | $75.23 |
| Q4 2020 | +13,169 | Add 16.24% | 94,265 | $68.30 |
| Q3 2020 | +10,158 | Add 14.32% | 81,096 | $58.40 |
| Q2 2020 | +18 | Add 0.03% | 70,938 | $64.97 |
| Q1 2020 | -286 | Reduce 0.40% | 70,920 | $59.33 |
| Q4 2019 | +71,207 | Add 0.00% | 71,206 | $74.29 |
Mark Hillman's CVS Health Corporation Investment FAQs
Mark Hillman first purchased CVS Health Corporation (CVS) in Q4 2019, acquiring 71,206 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mark Hillman has held CVS Health Corporation (CVS) for 25 quarters since Q4 2019.
Mark Hillman's largest addition to CVS Health Corporation (CVS) was in Q4 2019, adding 71,206 shares worth $5.29 M.
According to the latest 13F filing for Q4 2025, Mark Hillman's firm, Hillman Capital Management, Inc., owns 71,685 shares of CVS Health Corporation (CVS), valued at approximately $5.69 M.
As of the Q4 2025 filing, CVS Health Corporation (CVS) represents approximately 3.58% of Mark Hillman's publicly disclosed stock portfolio, making it one of their key holdings.
Mark Hillman's peak holding in CVS Health Corporation (CVS) was 124,329 shares, as reported at the end of Q2 2024.